Concerned about IgAN?

Categories: For Potential Participants, [Kidney Disease, Kidney & Urinary, Clinical Trials]

We are looking for people who may be interested in taking part in the PROTECT Study for immunoglobulin A nephropathy (IgAN). The clinical research study is looking at an investigational medication to see how safe it is and whether it works for people with IgAN. Clinical research studies need volunteers to help support rare disease communities, such as IgAN. Without these volunteers, fewer medical advances could be made. Learning more about IgAN could also help researchers to develop better medications in the future.

You may be eligible to participate in this kidney disease study if you:

• Have IgA nephropathy
• Have had a kidney biopsy (taking a small piece of tissue from your kidney)
• Have not had a kidney transplant
• Are not on dialysis

See if you may be able to take part in this kidney disease study. Learn more here: PROTECT Study

Keep up to date on the latest research

Interested in learning more about kidney disease research? Register on ClinicalResearch.com to receive news about kidney disease and related IQVIA clinical trials. Check ClinicalResearch.com often for updates and news on a variety of disease areas and to find out more about some of the latest clinical research trials.